Ma, X., Dong, L., Liu, X., Ou, K., & Yang, L. (2022). POLE/POLD1 mutation and tumor immunotherapy. Journal of Experimental & Clinical Cancer Research (17569966), 41(1), 1. https://doi.org/10.1186/s13046-022-02422-1
Chicago Style (17th ed.) CitationMa, Xiaoting, Lin Dong, Xiu Liu, Kai Ou, and Lin Yang. "POLE/POLD1 Mutation and Tumor Immunotherapy." Journal of Experimental & Clinical Cancer Research (17569966) 41, no. 1 (2022): 1. https://doi.org/10.1186/s13046-022-02422-1.
MLA (9th ed.) CitationMa, Xiaoting, et al. "POLE/POLD1 Mutation and Tumor Immunotherapy." Journal of Experimental & Clinical Cancer Research (17569966), vol. 41, no. 1, 2022, p. 1, https://doi.org/10.1186/s13046-022-02422-1.
Warning: These citations may not always be 100% accurate.